Abstract
The TEL gene, originally cloned by virtue of involvement in the t(5;12) chromosomal translocation associated with chronic myelomonocytic leukemia (CMML), has a remarkable capacity to contribute to the pathogenesis of human leukemias: (1) TEL has been implicated in both myeloid and lymphoid leukemias, acute and chronic leukemias, and leukemias of both pediatric and adult populations; (2) TEL can contribute either its DNA binding domain or a putative helix-loop-helix (HLH) domain to fusion proteins, and (3) TEL has been associated with a surprising variety of fusion partners in human leukemias, including genes for transcription factors, receptor and non-receptor tyrosine kinases, and putative transcriptional activating domains. In addition, recent evidence suggests that loss of function of TEL may also contribute to pathogenesis of malignancy. In this report, the diverse molecular genetic mechanisms of leukemogenesis mediated by the TEL gene will be discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Buijs A, Sherr S, van Baal S, van Bezouw S, van der Plas D, van Kessel AG, Riegman P, Deprez RL, Zwartoff E, Hagemeijer A, Grosveld G (1995) Translocation (12;22)(p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. Oncogene 10: 1511 – 1519
Golub TR, Barker GF, Lovett M, Gilliland DG (1994) Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77: 307 – 316
Golub T, Barker GF, Bohlander S, Hiebert SW, Ward DC, Bray-Ward P, Morgan E, Raimondi SC, Rowley JD, Gilliland DG (1995a) Fusion of the TEL gene on 12p13 to the AML1 gene on 12q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci 92: 4917 – 4921
Golub T, McLean T, Stegmaier K, Ritz J, Sallan S, Neuberg D, Gilliland DG (1995b) TEL-AML1: The most common gene rearrangement in childhood ALL. Blood (Suppl)
Golub TR, Goga A, Barker GF, Afar D, McLaughlin J, Bohlander SK, Rowley JD, Witte ON, Gilliland DG (1996) Oligomerization of the ABL tyrosine kinase by the ETS protein TEL in human leukemia. Mol Cell Biol (in press)
Nucifora G, Begy CR, Erickson P, Drabkin HA, Rowley JD (1993) The 3;21 translocation in myelo-dysplasia results in a fusion transcript between the AML1 gene and the gene for EAO, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1. Proc Natl Acad Sci USA 90: 7784 – 7788
Papadopoulos P, Ridge SA, Boucher CA, Stocking C, Wiedemann LM (1995) The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Res 55: 34 – 38
Pendergast AM, Quilliam LA, Cripe LD, Bessing CH, Dai Z, Li N, Der CJ, Sclessinger J, Gishizky ML (1993) BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adapter protein Cell 75: 175 – 185
Pui CH, Raimondi SC, Crist WM (1992) Chromosomal abnormalities in childhood acute lymphoblastic leukaemia. Recent Adv Haematol 6: 89 – 105
Raimondi SC, Williams DL, Callihan T, Peiper S, Rivera GK, Murphy SB (1986) Nonrandom involvement of the 12p12 breakpoint in chromosome abnormalities of childhood acute lymphoblastic leukemia. Blood 68: 69 – 75
Romana SP, Mauchauffe M, LeConiat M, LePaslier D, Berger R, Bernard OA (1995) The t(12;21) of acute lymphoblastic leukemia results in a TEL-AML1 gene fusion. Blood 85: 3662 – 3670
Sato Y, Suto Y, Pietenpol J, Golub TR, Gilliland DG, Davis EM, LeBeau MM, Roberts J, Vogelstein B, Rowley JD, Bohlander SK (1995) TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoeitic malignancies. Blood 86: 1525 – 1533
Shimizu K, Ichikawa H, Tojo A, Kaneko Y, Maseki N, Hayashi Y, Ohira M, Asano S, Ohki M (1993) An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(16;21) chromosomal translocation. Proc Natl Acad Sci USA 90: 10280 – 10284
Sorensen PHB, Lessnick AL, Lopez-Terrada D, Liu XF, Triche TJ, Denny CT (1994) A second Ewing’s sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nature Genetics 6: 146 – 151
Stegmaier K, Pendse S, Barker GF, Bray-Ward P, Ward DC, Montgomery KT, Krauter K, Reynolds C, Sklar J, Donnelly M, Bohlander SK, Rowley JD, Sallan SE, Gilliland DG, Golub TR (1995) Frequent loos of heterzygosity at the TEL gene locus in acute lymphoblastic leukemia of childhood. Blood 86: 38 – 44
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Golub, T.R., Barker, G.F., Stegmaier, K., Gilliland, D.G. (1997). The TEL Gene Contributes to the Pathogenesis of Myeloid and Lymphoid Leukemias by Diverse Molecular Genetic Mechanisms. In: Rauscher, F.J., Vogt, P.K. (eds) Chromosomal Translocations and Oncogenic Transcription Factors. Current Topics in Microbiology and Immunology, vol 220. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60479-9_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-60479-9_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64424-5
Online ISBN: 978-3-642-60479-9
eBook Packages: Springer Book Archive